Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study-Reference-Cited by-同舟云学术

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

Published:2023-02 Issue:2 Volume:55 Page:154-159
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Macaluso Fabio Salvatore^ORCID,Principi Mariabeatrice,Facciotti Federica,Contaldo Antonella,Todeschini Alessia,Saibeni Simone,Bezzio Cristina,Castiglione Fabiana,Nardone Olga Maria,Spagnuolo Rocco,Fantini Massimo Claudio,Riguccio Gaia,Caprioli Flavio,Viganò Chiara,Felice Carla,Fiorino Gionata,Correale Carmen,Bodini Giorgia,Milla Monica,Scardino Giulia,Vernero Marta,Desideri Federico,Mannino Mariella,Rizzo Giuseppe,Orlando Ambrogio,Amato Arnaldo,Ascolani Marta,Calabrese Giulio,Casà Angelo,Comberlato Michele,Conforti Francesco Simone,De Bona Manuela,Demarzo Maria Giulia,Doldo Patrizia,Dragoni Gabriele,Furfaro Federica,Mulinacci Giacomo,Olmo Oriana,O'Sed Nicole Piazza,Paba Salvatore,Radice Simona,Renna Sara,Ribaldone Davide Giuseppe,Rizzuto Giulia

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Rolling updates on coronavirus disease (COVID- 19). Updated 31 July 2020,2020

2. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting;Siegel;Gut,2021

3. Vaccinations in patients with inflammatory bowel disease;Macaluso;Dig Liver Dis,2021

4. COVID-19 vaccinations in patients with inflammatory bowel disease;Kumar;Lancet Gastroenterol Hepatol,2020

5. Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy;Pratt;Inflamm Bowel Dis,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0);Zeitschrift für Gastroenterologie;2024-04

2. Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving anti-TNF therapy: A systematic review and meta-analysis;Heliyon;2023-09

3. Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study;Inflammatory Bowel Diseases;2023-06-30

4. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD);European Journal of Gastroenterology & Hepatology;2023-04-04

5. COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment;Vaccines;2023-03-03